MedTrace Logo

Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer

NCT02075385 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2017-06-28

No results posted yet for this study

Summary

General Objective: To evaluate the swallowing results of speech pathologist rehabilitation of advanced oropharynges, larynx and hypopharynx cancer patients during neoadjuvant chemotherapy and radiotherapy concomitant to chemotherapy.

Methods and Casuistic: Randomized clinical trial phase II. 80 patients with advanced oropharynges, larynx and hypopharynx cancer diagnoses from Barretos Cancer Hospital, which had the proposal of neoadjuvant chemotherapy followed by radiotherapy combined with chemotherapy. Patients are randomized on two groups: control group and speech pathology therapy group

Conditions

  • Head Neck Cancer
  • Swallowing Disorders

Interventions

PROCEDURE

pre, during and pos-treatment swallowing exercises

Speech pathology therapy

Sponsors & Collaborators

  • Barretos Cancer Hospital

    lead OTHER

Principal Investigators

  • André L Carvalho, PHD · Fundação Pio XII - Hospital de Câncer de Barretos

  • Luciano S Viana, PHD · Fundação Pio XII - Hospital de Câncer de Barretos

  • Alexandre Jacinto, MD · Fundação Pio XII - Hospital de Câncer de Barretos

  • Juliana Portas, MSC · Fundação Pio XII - Hospital de Câncer de Barretos

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-11-30
Completion
2015-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02075385 on ClinicalTrials.gov